GNI GNI GROUP LTD.

Contact Us
About Us
  • About Us TOP
  • Message
  • Business Model
  • Main Products
  • Management Policy
  • Company Overview
  • Board of Directors
  • Main Group Structure
  • Office
  • Corporate governance
R&D
  • R&D TOP
  • Pipeline
  • Discovery Research
  • Research publications
Investor Relations
  • Investor Relations TOP
  • IR News
  • Information
  • IR Materials
  • IR Calendar
  • IR Email Subscription
  • Electronic Public Notices
Sustainability/ESG
  • Sustainability/ESG TOP
  • Sustainability Initiatives
  • ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー

2010's Information

トップページInformation2010年
2010/11/29
Notice of investments in China
2010/11/16
Notice of Increasing the Capital of Shanghai Genomics
2010/10/20
GNI Receives F351 Patent Allowance in Japan
2010/10/17
The 12th National Clinical Pharmacology Conference
2010/09/17
Shanghai Genomics Issued US Patent Covering F351
2010/09/17
Pharmaceutical & Biotechnology Pioneer Forum 2010
2010/08/26
GNI Receives F351 Patent Allowance in Canada
2010/07/30
Notice of reaching agreement for co-development of F351 in China
2010/07/26
Shanghai Genomics Reports Human Phase I Trial Data of F351
2010/07/20
BioBusiness Asia Conference 2010
  • 1
  • 2
  • 3
  • 4
  • >
画像

GNI

About Us
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate Governance Policy
Investor Relations
IR News
IR Materials
IR Calendar
Electronic Public Notices
IR Email Subscription
R&D
Pipeline
Discovery Research
Research publications
Sustainability/ESG
Sustainability Initiatives
ESG Data
Contact Us
Career
Site Map
Privacy Policy
Terms of Use
Social Media Policy
Site Map
Privacy Policy
Terms of Use
Social Media Policy

© GNI Group Ltd. All Rights Reserved.